Alkido Pharma Stock Price

0.0665 (8.26%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Alkido Pharma Inc AIKI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0665 8.26% 0.8712 17:04:37
Open Price Low Price High Price Close Price Prev Close
0.8169 0.771 0.9572 0.896 0.8047
Bid Price Ask Price Spread News
0.8711 0.875 0.0039 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
28,129 30,720,353 $ 0.8601285 $ 26,423,451 - 0.4656 - 2.55
Last Trade Time Type Quantity Stock Price Currency
17:04:37 formt 1,000 $ 0.8712 USD


Draw Mode:

Alkido Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 78.47M 89.68M 89.50M $ - $ - -0.99 -7.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 150.00k 2.00%

more financials information »

Alkido Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AIKI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.7270.95720.7230.79903951,952,5610.144219.83%
1 Month0.800.95720.7210.78091691,803,7230.07128.9%
3 Months0.931.010.720.82419821,305,932-0.0588-6.32%
6 Months1.161.210.720.97553492,493,125-0.2888-24.9%
1 Year0.552.550.46561.246,656,0850.321258.4%
3 Years1.035.520.46561.253,320,678-0.1588-15.42%
5 Years1.255.520.46561.312,153,048-0.3788-30.3%

Alkido Pharma Description

AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.

Your Recent History
Alkido Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.